Digital Marketing Skills Report Reveals 2022 Ranking of Biopharma Brands Based on Digital Patient Experiences | Nation/World

WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 15, 2022–

Trinity Life Sciences, a leader in global life sciences commercialization solutions, has released its second annual TGaS Digital Marketing Skills Report evaluating more than 160 biopharmaceutical brands through the lens of digital patient experiences. The new study assesses brands across five categories and 60 unique metrics to understand each’s digital marketing presence.

The Digital Marketing Skills report ranks each individual brand on a scale from transformational to novice. It also examines the influence of spend, time-to-market, therapeutic areas, and impact on individual channels to give organizations unparalleled insight into not only their own valuation, but their competitors as well.

“The rapid evolution of omnichannel execution and patient centricity has led to a hyperfocus on how brands invest in and measure the effectiveness of digital marketing,” said Jerry Luciano, vice president of omnichannel marketing, at TGaS Advisors, a division of Trinity Life Sciences. “Now more than ever, it’s critical that organizations understand what they need to do to optimize the digital patient experience. This ranking helps put some of the world’s most important brands in context and provides insight into how some of the biggest brands excel.

Brands that topped the list in the 2022 Digital Marketing Skills Report include:

Find out what sets some brands apart from others. To download the summary of the report with the ranking of more than 160 brands, go to TrinityLifeSciences.com or click here. The full report, including in-depth channel and trend analysis, is available to members of the TGaS Omnichannel Marketing Network.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for life sciences. With 25 years of experience, Trinity is committed to revolutionizing the business model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s portfolio of products and solutions includes industry-leading benchmarking solutions powered by TGaS advisors. To learn more about how Trinity is elevating life sciences and turning evidence into action, visit trinitylifesciences.com.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20221115005509/en/

CONTACT: Media:

Elizabeth Marshall

Trinity Life Sciences

emarshall@trinitylifesciences.com

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH TECHNOLOGY TELEMEDICINE/VIRTUAL MEDICINE OTHER TECHNOLOGIES GENERAL HEALTH BIOTECHNOLOGY PHARMACEUTICALS

SOURCE: Trinity Life Sciences

Copyright BusinessWire 2022.

PUBLISHED: 11/15/2022 8:37 AM / DISK: 11/15/2022 8:37 AM

http://www.businesswire.com/news/home/20221115005509/en

Copyright BusinessWire 2022.

Source link

About Alex S. Crone

Check Also

25 classic American brands now owned by foreign companies – 24/7 Wall St.

Special report November 16, 2022 11:54 a.m. Promoting entrepreneurship has been a cornerstone of America’s …